If you need more lookups,
subscriptions start at $34 USD/month.
Boris Rogovoy Location
Boston, MA, US
Boris Rogovoy Work
2021 -now Senior Director of Discovery Programs @
2020 -2021 Director of Medicinal Chemistry @
2018 -2019 Director, Medicinal Chemistry @
2018 -2019 Director, Medicinal Chemistry and Discovery Services @ ChemSpace
2014 -2018 Head of Chemistry @
2012 -2018 Director of Research and Development @
2004 -2012 Senior Scientist @
2003 -2004 Assistant Research Scientist @ Rutgers University Earnst Mario School of Pharmacy
1998 -2003 Scientist @ Center for Heterocyclic Compounds, Gainesville, FL
1998 -2003 Scientist @ University of Florida
Boris Rogovoy Education
University of Tartu
PhD (Organic Chemistry)
2000-2002
University of Florida
Boris Rogovoy Skills
Drug Discovery
Drug Design
Medicinal Chemistry
Organic Synthesis
Purification
Organic Chemistry
Chemistry
Biotechnology
Lifesciences
Protein Chemistry
HPLC
In Vitro
Assay Development
Cell
Pharmaceutical Industry
LC-MS
Analytical Chemistry
Molecular Biology
NMR
Drug Development
Clinical Development
R&D
Biochemistry
High Throughput Screening
Oncology
Cancer
Neuroscience
Combinatorial Chemistry
CRO
Chromatography
Technology Transfer
Biopharmaceuticals
Mass Spectrometry
Lead Change
Pharmacology
GLP
Immunology
Cell Biology
Cell Culture
ELISA
Fluorescence
Protein Purification
Spectroscopy
Catalysis
UV/Vis
Pharmacokinetics
Heterocyclic Chemistry
Genomics
Science
Life Sciences
Lc Ms
Boris Rogovoy Summary
Boris Rogovoy, based in Boston, MA, US, is currently a Senior Director of Discovery Programs at Viriom Inc. Boris Rogovoy brings experience from previous roles at DeepCure, Enamine Ltd., ChemSpace and Chromis Therapeutics. Boris Rogovoy holds a 2000 - 2002 PhD in Organic Chemistry @ University of Tartu. With a robust skill set that includes Drug Discovery, Drug Design, Medicinal Chemistry, Organic Synthesis, Purification and more. Boris Rogovoy has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Boris Rogovoy?
Find contact details for 700 million professionals.